RESUMO
Probiotics have been associated with a variety of health benefits. They can act as adjuvant to enhance specific immune response. Bacterial cell wall (CW) molecules are key structures that interact with host receptors promoting probiotic effects. The adjuvant capacity underlying this sub-cellular fraction purified from Lactobacillus casei CRL431 and L. paracasei CNCMI-1518 remains to be characterized. We interrogated the molecular and cellular events after oral feeding with probiotic-derived CW in addition to heat-inactivated Salmonella Typhimurium and their subsequent protective capacity against S. Typhimurium challenge. Intact probiotic bacteria were orally administered for comparison. We find that previous oral feeding with probiotics or their sub-cellular fraction reduce bacterial burden in spleen and liver after Salmonella challenge. Antibody responses after pathogen challenge were negligible, characterized by not major changes in the antibody-mediated phagocytic activity, and in the levels of total and Salmonella-specific intestinal sIgA and serum IgG, respectively. Conversely, the beneficial effect of probiotic-derived CW after S. Typhimurium challenge were ascribed to a Th1-type cell-mediated immunity which was characterized by augmentation of the delayed-type hypersensitivity response. The cell-mediated immunity associated with the oral feeding with probiotic-derived CW was accompanied with a Th1-cell polarizing cytokines, distinguished by increase IFN-γ/IL-4 ratio. Similar results were observed with the intact probiotics. Our study identified molecular events associated with the oral administration of sub-cellular structures derived from probiotics and their adjuvant capacity to exert immune modulatory function.
Assuntos
Parede Celular/imunologia , Lacticaseibacillus casei/imunologia , Lacticaseibacillus paracasei/imunologia , Probióticos/administração & dosagem , Infecções por Salmonella/imunologia , Salmonella typhimurium/imunologia , Células Th1/imunologia , Adjuvantes Imunológicos/administração & dosagem , Administração Oral , Animais , Anticorpos Antibacterianos/sangue , Citocinas/imunologia , Imunidade Celular , Lacticaseibacillus casei/química , Lacticaseibacillus paracasei/química , Macrófagos/imunologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , FagocitoseRESUMO
The aim of this study was to assess the protective effect of the intracellular content obtained from potential probiotic bacteria against acrylamide-induced oxidative damage in human erythrocytes. First, the antioxidant properties of 12 potential probiotic strains was evaluated. Two commercial probiotic bacteria were included as reference strains, namely, Lactobacillus casei Shirota and Lactobacillus paracasei 431. Data showed that the intracellular content from four strains, i.e., Lactobacillus fermentum J10, Lactobacillus pentosus J24 and J26, and Lactobacillus pentosus J27, showed higher (P < 0.05) antioxidant capacity in most methods used. Thereafter, the intracellular content of such pre-selected strains was able to prevent the disturbance of the antioxidant system of human erythrocytes exposed to acrylamide, thereby reducing cell disruption and eryptosis development (P < 0.05). Additionally, the degree of oxidative stress in erythrocytes exposed to acrylamide was significantly (P < 0.05) reduced to levels similar to the basal conditions when the intracellular content of Lact. fermentum J10, Lact. pentosus J27, and Lact. paracasei 431 were employed. Hence, our findings suggest that the intracellular contents of specific Lactobacillus strains represent a potential source of metabolites with antioxidant properties that may help reduce the oxidative stress induced by acrylamide in human erythrocytes.
Assuntos
Acrilamida/farmacologia , Antioxidantes/farmacologia , Misturas Complexas/farmacologia , Lacticaseibacillus casei/química , Lacticaseibacillus paracasei/química , Lactobacillus pentosus/química , Limosilactobacillus fermentum/química , Acrilamida/antagonistas & inibidores , Antioxidantes/química , Catalase/metabolismo , Células Cultivadas , Cromanos/farmacologia , Misturas Complexas/química , Eritrócitos/citologia , Eritrócitos/efeitos dos fármacos , Eritrócitos/metabolismo , Glutationa/metabolismo , Glutationa Peroxidase/metabolismo , Hemólise/efeitos dos fármacos , Humanos , Lacticaseibacillus casei/metabolismo , Limosilactobacillus fermentum/metabolismo , Lacticaseibacillus paracasei/metabolismo , Lactobacillus pentosus/metabolismo , Malondialdeído/antagonistas & inibidores , Malondialdeído/metabolismo , Oxirredução , Estresse Oxidativo , Probióticos/química , Superóxido Dismutase/metabolismoRESUMO
The aims of the present study were to develop and evaluate different formulations of probiotic and synbiotic sorbets produced with jussara (Euterpe edulis) pulp, polydextrose, Lactobacillus acidophilus LA3, and Lactobacillus paracasei BGP1. The pasteurized jussara pulp presented high content of phenolic compounds, especially anthocyanins, which were not inhibitory to the probiotics used in this study. The levels of polyphenols and anthocyanins present in the sorbets were also high and kept stable for 120 days, as well as the populations of both probiotics. On the other hand, probiotic populations reduced ca. 4 log CFU/g when exposed to simulated gastrointestinal fluids. Altogether, the sorbets produced in this study showed interesting results, indicating the viability on producing functional foods with probiotics, prebiotics, and other components that are rich in polyphenols, such as jussara pulp. The combination of these elements can improve the health beneficial effects of these compounds and provide important advantages to the intestinal microbiota of consumers.
Assuntos
Euterpe/química , Trato Gastrointestinal/microbiologia , Lacticaseibacillus paracasei/química , Lactobacillus acidophilus/química , Extratos Vegetais/química , Prebióticos/análise , Probióticos/química , Simbióticos/análise , Armazenamento de Medicamentos , Humanos , Lactobacillus acidophilus/metabolismo , Lacticaseibacillus paracasei/metabolismo , Modelos Biológicos , Resíduos/análiseRESUMO
Probiotics are live microorganisms which, when administered in adequate amounts, confer a health benefit on the host. The aim of this study was to identify genotypically lactobacilli strains isolated from newborn stools and selecting strain based on probiotic properties (gastrointestinal tolerance, antibiotic susceptibility, inhibition of pathogen biofilm formation, absence of alfa or gamma-blood hemolysis, and lysozyme sensibility) and technological properties of surviving either in ice cream bar or ice-lolly. Reduction of 1.2log cfu ml-1 of the Lactobacillus paracasei strain was observed after exposure through in vitro gastrointestinal conditions. It inhibited biofilms of Escherichia coli, Salmonella Typhimurium and Candida albicans by mechanisms of competition, exclusion and displacement, and was resistant up to 3000μg ml-1 of egg white lysozyme. It presented neither alfa nor gamma-hemolysis or was antibiotic resistant to usual antibiotics for human use. Microbial survivability in ice cream bar or ice-lolly was assessed up to 21 days of storage at -18°C. Viability was maintained in ice cream bar, but there was a reduction of almost 2.0logs in ice-lolly.(AU)
Probióticos são microrganismos vivos que, quando administrados em quantidade adequadas, conferem benefícios à saúde do hospedeiro. O objetivo desta pesquisa foi identificar genotipicamente lactobacilos isolados de material fecal de recém-nascidos, assim como selecionar uma cepa com base em suas propriedades probióticas (tolerância às condições gastrointestinais, susceptibilidade à antibióticos, inibição da formação de biofilmes por microrganismos patogênicos, ausência de hemólise alfa ou gama e sensibilidade à lisozima) e tecnológicas de sobrevivência em picolé à base de água ou leite. Houve redução de 1,2log ufc ml-1 do isolado identificado como Lactobacillus paracasei após passagem pelas condições gastrointestinais in vitro. Esta cepa inibiu a formação de biofilmes de Escherichia coli, Salmonella Typhimurium e Candida albicans pelos mecanismos de competição, exclusão e desacoplamento e apresentou resistência até 3000μg ml-1 frente a lisozima de ovo. Entre os aspectos de segurança, a cepa não apresentou hemólise alfa ou gama e não foi resistente a antibióticos comumente ministrados em humanos. A sobrevivência microbiana em picolé a base de água ou leite foi analisada ao longo de 21 dias de estocagem a -18°C. Houve manutenção da viabilidade no produto à base de leite, mas naquele à base de água, ocorreu redução de quase 2,0logs.(AU)